ACW
Click for more information
4.05% 7.1¢ actinogen medical limited

Ann: Appendix 4E & Financial Statements, page-2

  1. Counterfiat
    810 Posts.
    lightbulb Created with Sketch. 40
    clock Created with Sketch.
    18/08/17
    23:46
    Post #: 26603532
    'the Company is expecting an Australian Government R&D Tax Incentive rebate of approximately $1.2 million in the first quarter of the 2018 financial year relating to R&D spend during FY2017. '

    and US rebate?
    ACW Price at posting: 5.3¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
7.1¢ 		Change
-0.003(4.05%) 		Mkt cap ! $191.2M
Open High Low Value Volume
7.3¢ 7.9¢ 6.9¢ $1.067M 14.27M

Buyers (Bids)

No. Vol. Price($)
1 307386 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 76342 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.